Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Plos One
|
December 31, 2016
Concentrations of Pro-Inflammatory Cytokines Are Not Associated with Senescence Marker p16INK4a or Predictive of Intracellular Emtricitabine/Tenofovir Metabolite and Endogenous Nucleotide Exposures in Adults with HIV Infection
Brian M Maas, Owen Francis, Katie R Mollan, et al.
Plos Pathogens
|
December 7, 2023
Deep analysis of CD4 T cells in the rhesus CNS during SIV infection
Sonny R Elizaldi, Anil Verma, Zhong-Min Ma, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 22, 2016
Cervicovaginal and Rectal Fluid as a Surrogate Marker of Antiretroviral Tissue Concentration: Implications for Clinical Trial Design
Mackenzie L Cottrell, Heather M A Prince, Andrew Allmon, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 5, 2024
Next-generation 3D printed multipurpose prevention intravaginal ring for prevention of HIV, HSV-2, and unintended pregnancy
Denali K Dahl, Priya Srinivasan, Rima Janusziewicz, et al.
Pharmaceutics
|
February 24, 2024
Pharmacokinetic Modeling to Guide Preclinical Development of an Islatravir-Eluting Reservoir-Style Biodegradable Implant for Long-Acting HIV PrEP
Talisa S Kinsale, Mackenzie L Cottrell, Linying Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 10, 2019
Decreased Tenofovir Diphosphate Concentrations in a Transgender Female Cohort: Implications for Human Immunodeficiency Virus Preexposure Prophylaxis
Mackenzie L Cottrell, Heather M A Prince, Amanda P Schauer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 27, 2025
Ultra-long-acting injectable, biodegradable, and removable in-situ forming implant with cabotegravir for HIV prevention
Thy Le, Isabella C Young, Jasmine L King, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 15, 2025
A Cross-Biomeasure Study to Optimize Antiretroviral Adherence Estimation
Aaron S Devanathan, Amanda J Poliseno, Nicole R White, et al.
The Journal of Infectious Diseases
|
February 27, 2016
A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine
Mackenzie L Cottrell, Kuo H Yang, Heather M A Prince, et al.
Journal of Virology
|
June 22, 2018
Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques
Egidio Brocca-Cofano, Cuiling Xu, Katherine S Wetzel, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Plos One
|
December 31, 2016
Concentrations of Pro-Inflammatory Cytokines Are Not Associated with Senescence Marker p16INK4a or Predictive of Intracellular Emtricitabine/Tenofovir Metabolite and Endogenous Nucleotide Exposures in Adults with HIV Infection
Brian M Maas, Owen Francis, Katie R Mollan, et al.
Plos Pathogens
|
December 7, 2023
Deep analysis of CD4 T cells in the rhesus CNS during SIV infection
Sonny R Elizaldi, Anil Verma, Zhong-Min Ma, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 22, 2016
Cervicovaginal and Rectal Fluid as a Surrogate Marker of Antiretroviral Tissue Concentration: Implications for Clinical Trial Design
Mackenzie L Cottrell, Heather M A Prince, Andrew Allmon, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 5, 2024
Next-generation 3D printed multipurpose prevention intravaginal ring for prevention of HIV, HSV-2, and unintended pregnancy
Denali K Dahl, Priya Srinivasan, Rima Janusziewicz, et al.
Pharmaceutics
|
February 24, 2024
Pharmacokinetic Modeling to Guide Preclinical Development of an Islatravir-Eluting Reservoir-Style Biodegradable Implant for Long-Acting HIV PrEP
Talisa S Kinsale, Mackenzie L Cottrell, Linying Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 10, 2019
Decreased Tenofovir Diphosphate Concentrations in a Transgender Female Cohort: Implications for Human Immunodeficiency Virus Preexposure Prophylaxis
Mackenzie L Cottrell, Heather M A Prince, Amanda P Schauer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 27, 2025
Ultra-long-acting injectable, biodegradable, and removable in-situ forming implant with cabotegravir for HIV prevention
Thy Le, Isabella C Young, Jasmine L King, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 15, 2025
A Cross-Biomeasure Study to Optimize Antiretroviral Adherence Estimation
Aaron S Devanathan, Amanda J Poliseno, Nicole R White, et al.
The Journal of Infectious Diseases
|
February 27, 2016
A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine
Mackenzie L Cottrell, Kuo H Yang, Heather M A Prince, et al.
Journal of Virology
|
June 22, 2018
Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques
Egidio Brocca-Cofano, Cuiling Xu, Katherine S Wetzel, et al.
Page
of 8